| UniProt ID | MTHR_HUMAN | |
|---|---|---|
| UniProt AC | P42898 | |
| Protein Name | Methylenetetrahydrofolate reductase {ECO:0000305} | |
| Gene Name | MTHFR | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 656 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine.. | |
| Protein Sequence | MVNEARGNSSLNPCLEGSASSGSESSKDSSRCSTPGLDPERHERLREKMRRRLESGDKWFSLEFFPPRTAEGAVNLISRFDRMAAGGPLYIDVTWHPAGDPGSDKETSSMMIASTAVNYCGLETILHMTCCRQRLEEITGHLHKAKQLGLKNIMALRGDPIGDQWEEEEGGFNYAVDLVKHIRSEFGDYFDICVAGYPKGHPEAGSFEADLKHLKEKVSAGADFIITQLFFEADTFFRFVKACTDMGITCPIVPGIFPIQGYHSLRQLVKLSKLEVPQEIKDVIEPIKDNDAAIRNYGIELAVSLCQELLASGLVPGLHFYTLNREMATTEVLKRLGMWTEDPRRPLPWALSAHPKRREEDVRPIFWASRPKSYIYRTQEWDEFPNGRWGNSSSPAFGELKDYYLFYLKSKSPKEELLKMWGEELTSEESVFEVFVLYLSGEPNRNGHKVTCLPWNDEPLAAETSLLKEELLRVNRQGILTINSQPNINGKPSSDPIVGWGPSGGYVFQKAYLEFFTSRETAEALLQVLKKYELRVNYHLVNVKGENITNAPELQPNAVTWGIFPGREIIQPTVVDPVSFMFWKDEAFALWIERWGKLYEEESPSRTIIQYIHDNYFLVNLVDNDFPLDNCLWQVVEDTLELLNRPTQNARETEAP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | LNPCLEGSASSGSES CCCCCCCCCCCCCCC | 18.66 | 16024724 | |
| 20 | Phosphorylation | PCLEGSASSGSESSK CCCCCCCCCCCCCCC | 36.61 | 16024724 | |
| 21 | Phosphorylation | CLEGSASSGSESSKD CCCCCCCCCCCCCCC | 46.16 | 16024724 | |
| 26 | Phosphorylation | ASSGSESSKDSSRCS CCCCCCCCCCCCCCC | 36.11 | 16024724 | |
| 29 | Phosphorylation | GSESSKDSSRCSTPG CCCCCCCCCCCCCCC | 24.34 | 27251275 | |
| 30 | Phosphorylation | SESSKDSSRCSTPGL CCCCCCCCCCCCCCC | 47.65 | 27251275 | |
| 33 | Phosphorylation | SKDSSRCSTPGLDPE CCCCCCCCCCCCCHH | 36.20 | 28060719 | |
| 34 | Phosphorylation | KDSSRCSTPGLDPER CCCCCCCCCCCCHHH | 25.63 | 21815630 | |
| 90 | Phosphorylation | MAAGGPLYIDVTWHP HHCCCCEEEEEEEEC | 9.75 | - | |
| 151 | Ubiquitination | KAKQLGLKNIMALRG HHHHHCCCHHHHHCC | 42.50 | - | |
| 212 | Ubiquitination | GSFEADLKHLKEKVS CCHHHHHHHHHHHHH | 47.65 | - | |
| 273 | Ubiquitination | RQLVKLSKLEVPQEI HHHHHHHCCCCCHHH | 60.13 | - | |
| 281 | Ubiquitination | LEVPQEIKDVIEPIK CCCCHHHHHHHHHCC | 45.23 | - | |
| 288 | Ubiquitination | KDVIEPIKDNDAAIR HHHHHHCCCCCHHHH | 62.28 | - | |
| 329 | Phosphorylation | TLNREMATTEVLKRL ECCHHHHHHHHHHHH | 23.37 | - | |
| 330 | Phosphorylation | LNREMATTEVLKRLG CCHHHHHHHHHHHHC | 17.98 | - | |
| 372 | Ubiquitination | IFWASRPKSYIYRTQ CEECCCCCCEEEECC | 55.57 | - | |
| 392 | Phosphorylation | PNGRWGNSSSPAFGE CCCCCCCCCCCCCHH | 28.40 | 29978859 | |
| 393 | Phosphorylation | NGRWGNSSSPAFGEL CCCCCCCCCCCCHHH | 44.32 | 29978859 | |
| 394 | Phosphorylation | GRWGNSSSPAFGELK CCCCCCCCCCCHHHC | 21.77 | 29978859 | |
| 414 | Ubiquitination | YLKSKSPKEELLKMW EECCCCHHHHHHHHH | 71.55 | - | |
| 465 | Phosphorylation | EPLAAETSLLKEELL CCCHHHHHHHHHHHH | 24.18 | 24719451 | |
| 468 | Ubiquitination | AAETSLLKEELLRVN HHHHHHHHHHHHCCC | 55.20 | - | |
| 549 | Phosphorylation | NVKGENITNAPELQP EECCCCCCCCCCCCC | 36.59 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTHR_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTHR_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of MTHR_HUMAN !! | ||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| 236250 | Methylenetetrahydrofolate reductase deficiency (MTHFRD) |
| 603174], developmental delay, severe mental retardation, perinatal death, psychiatric disturbances, and later-onset neurodegenerative disorders. {ECO | |
| Ischemic stroke (ISCHSTR) [ | DISEASE |
| 601634 | Neural tube defects, folate-sensitive (NTDFS) |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00542 | Benazepril |
| DB00115 | Cyanocobalamin |
| DB00544 | Fluorouracil |
| DB00158 | Folic Acid |
| DB00134 | L-Methionine |
| DB00170 | Menadione |
| DB00563 | Methotrexate |
| DB00140 | Riboflavin |
| DB00116 | Tetrahydrofolic acid |
loading...